INTRODUCTION
This review stems from a previous report (143) in which the biochemical mechanisms of bacterial pathogenicity formed the main subject and were discussed in a manner which prompted the following questions regarding the pathogenicity of other, less-studied microbes including viruses. Can differences in virulence be detected and measured in vivo? Are reasonably stable virulent and avirulent strains available so that virulence markers and determinants can be recognized (i) by comparing the behavior of the strains in vitro and in vivo and (ii) by observing the effects of the products of the virulent strain on the behavior of the avirulent strain? How far can avirulence be due to any inherent inability to grow in host tissues (as distinct from an inability to combat host defense mechanisms)? What host defense mechanisms act against the microbe and what aggressions inhibit them? Are the pathological effects of the disease due to production of toxins (acting intracellularly or systemically, or both), depletion of nutrients, mechanical blockage of vital tissues, or evocation of hypersensitivity or auto-allergic reactions? Can host and tissue specificities be explained either by differential distribution of microbial inhibitors or differential suitability of tissues for microbial growth?
At the time, only incomplete answers to these questions could be provided for viruses due to lack of space and knowledge. Now more information has accumulated (148) , and the object of the present review is a more comprehensive discussion of these and other questions relating to the pathogenicity of viruses. The review is written from the standpoint of one who has entered the field of virus pathogenicity from studies of bacterial pathogenicity, and whose predominant impression is that the broad aspects of pathogenicity of the two microbial types are similar despite the obligate parasitism of viruses. In particular, viral-like bacterial pathogenicity is not determined solely by biochemical ability to replicate in host tissues; virulent and attenuated strains of viruses replicate in host cells in vitro, yet they differ fundamentally in behavior in vivo, presumably-as for bacteria-due to different capacities to counteract host defense mechanisms and to damage tissues. Also, the fact that the viral factors responsible for virulence mechanisms are induced within host cells does not confer uniqueness on viral pathogenicity. Although replicating by different processes, many pathogenic microbes (including bacteria) are intracellular parasites, and often bacterial virulence factors that are produced extracellularly enter and act within host cells, e.g., the interference with protein synthesis by the toxin of Corynebacterium diphtheriae. Even the latency of viruses has its parallel in the carrier state of bacteriology. Finally, animal experiments with viruses are as essential as those with bacteria, for many aspects of pathogenic behavior in vivo are missing in tissue culture experiments (142) .
It is hoped the reader will use the previous review (143) as a basis for what follows. The terms "pathogenicity" and "virulence" are nearly synonymous and mean the capacity to produce disease; as suggested by Miles (93) , virulence is used here mainly with respect to comparisons of the disease-producing capacities of strains within a species. Tumor viruses have been largely excluded from the review since their pathogenicity is a special case requiring separate treatment. Also, latency has not been specifically discussed, because the phenomenon has been described many times, there is little real knowledge of the mechanisms involved, and the speculations on their nature are well known (98) .
QUANTITATIVE COMPARISONS OF VIRULENCE: PROPERTIES OF VIRULENT AND ATTENUATED STRAINS Although mechanisms of pathogenicity can be investigated by using a single strain of virus, the existence of stable strains of differing virulence greatly increases the experimental scope in the search for virulence markers and determinants. Different virus strains exist, and advances in viral genetics (48) will increase the number available, but quantitative comparison of their virulence is difficult because of the low efficiency of viable counts. The effects in animals (LDO, lesion size, or mean death time for the "same" dose) must be related to amounts of virus particles indicated by plaque counts or egg infection. The latter detects only a small proportion of the total virus particles and therefore may not measure all the particles (which could vary for different strains) capable of multiplying in experimental animals. For example, plaque counts on chick embryo fibroblasts detected less infectious particles of Semliki Forest virus than infection of suckling mice (20) , and in this system the proportion of total virus particles detected by the plaque counts was fairly high (approximately 1 in 10) compared with many other virus systems. Thus, for this and other reasons, comparisons of the virulence of virus strains are often imprecise. Burrows (24) , for example, has described the imprecision of virulence comparisons between strains of foot-and-mouth disease virus and the lack of correlation with behavior in the field.
Only virus strains for which conventional tests have indicated large differences in virulence should be compared to recognize virulence markers and determinants. Comparisons of such well-tested and well-separated strains have been rare (14, 164) but informative. Attenuated strains of poliovirus had less affinity than virulent strains for the cell receptors of primate central nervous system (65) . Virulent strains of ectromelia virus had a greater capacity to infect mouse macrophages than attenuated strains, although they had equal ability to infect hepatic cells (95) . Well-tested strains of Semliki Forest virus of widely different virulence (20) have been examined in mice (121) . Surprisingly, in view of the wide difference in virulence, and in contrast with studies on less well-defined strains of Japanese B encephalitis virus (70) , muscle replication and systemic infection of the attenuated strain was at least as high, if not higher, than that of the virulent strain; only in the brain was virus replication higher for the virulent strain than for the attenuated strain (121) . Because (42, 80, 118, 161) and need not be repeated here.
What factors determine the initial site of virus lodgement? In the respiratory tract, the size of the droplet to which the virus is attached is the prime factor (42), but some differences in deposition occur in different animal species due to different size, anatomy, and posture (24) . Within one species, small differences in anatomy and breathing pattern can influence deposition of virus (134) . Apart from these mechanical factors, chemical factors which might determine tissue specificity (16, 17) may play a role in primary lodgement if present in the pathway of the incoming virus. The site of virus deposition can influence the subsequent pathogenesis of the disease. A recent reinvestigation (24) of the pathogenesis of foot-and-mouth disease following the discovery that the disease can be aerosoltransmitted showed differences in disease development according to whether initial infection occurred through the natural site, the pharyngeal region, or through tongue epithelium formerly thought to be the natural site.
How do viruses penetrate the moving mucus blanket which sweeps particles towards the pharynx? Mucus depth and speed of flow are obviously important in this process. Little is known of the depth and nature of mucus in different parts of the respiratory tract, although it appears that the cilia beat in a watery layer underlying a stiffer particle transporting layer, and in the lower respiratory tract mucus thickness decreases and the composition changes (37, 80, 118) . Mucus flow rates are better understood. There is a velocity gradient from small to large airways (4) and individual rates can vary widely, for example, 4-fold in chickens and 10-fold in humans (11, 122) . Obstructions in the tract such as bronchial junctions and protrusions can produce local changes in flow rate (42) . Many factors affect mucous secretion and ciliary action (11, 118, 166) , including ion concentration in the air, temperature, and humidity; the last two affect nasal epithelium rather than lower parts of the tract where the air has been preheated and humidified. Clearly, the thinner the mucus and the slower the rate of flow, the more likely the occurrence of epithelial infection or penetration. This has been demonstrated experimentally. Reduction of nasomucociliary activity of chicks by exposure to low temperature or by injections of cocaine or pilocarpine increased infection rates with a standard exposure of Newcastle disease virus (11, 13) . What happens in natural infection is still a matter of conjecture. Viral infection should occur more easily in the lower than in the upper respiratory tract because of a slower movement of a thinner protective film. Mucus flow might be almost stationary at respiratory tract obstructions, thus providing foci for virus attack (42) ; or gaps in the mucus coat might occur, exposing the underlying tissue (118) . However, in epidemics, infection occurs in too many individuals to implicate simultaneous impairment of mucociliary action. The penetration mechanisms operating in many virus infections may have little connection with variations of the mucous blanket and may reside in the properties of the virus itself, such as an extra affinity for the surface receptors or phagocytic action of susceptible mucosal cells against which they brush during the mucociliary movement. Better techniques for observing the behavior of small numbers of virus particles on mucous surfaces will be needed before these possibilities can be investigated.
If mucus contains virus inhibitors, how do virulent viruses counteract them? There is little doubt that mucus can inhibit or kill some viruses. The slightly alkaline pH inactivates some viruses, such as foot-and-mouth disease virus (24) , and nonspecific inhibitory substances have been found in mucus and homogenates of mucosae (123) . Perhaps the major antiviral activity in respiratory and alimentary tract mucus resides in specific immunoglobulins (largely immunoglobulin A) arising from previous infections or immunization (74, 159 (92) does not exist. However, sequential determinations of virus contents of tissues, the resultants of virus replication, destruction, and removal, indicate in some instances a more rapid replication of virulent strains than avirulent strains either in the tissues generally or in a vital site (14, 121) . Also, some support for a connection between the replication rate and virulence comes from tissue culture studies. For strains of some (65) but not all viruses (138) , there is a relation between plaque size and virulence, and, although the size of the plaque can be determined by cytotoxic factors (3, 125, 127) and not by rate of replication, in some cases the latter seems the dominant factor (132, 164) .
Ability to proliferate in vivo depends on an inherent ability to replicate in the biochemical conditions of the host tissues, coupled with a capacity to resist or not to stimulate host defense mechanisms which would otherwise kill or remove them. Distinguishing between these effects is not easy for any type of microbe (147) , but it is particularly difficult for viruses because of the absolute parasitism involved. The cellular factors required for virus replication are complex (104) , and it is almost impossible, with present techniques, to distinguish clearly the influence of their absence in a particular situation from the influence of host factors (defense mechanisms) which destroy virus or interfere with replication. Nevertheless, the distinction has been made occasionally, for example, when lack of replication has been shown to be due to the host defense mechanism, interferon (15, 31) . And further attempts to distinguish "replication factors" (147) from host defense factors seem worthwhile, since they may lead to the recognition of virus-induced products which inactivate or resist host defense factors (e.g., interferon antagonists). Ability to replicate and interference with host defense factors are discussed in this and the following sections.
The ability of a virus to replicate in a particular cell depends on inherent features of the cell (104) as well as the virus. These features can be involved in one or more stages of replication: attachment, penetration, uncoating, provision of energy and precursors of low-molecular-weight, nucleic acid and protein synthesis, assembly, and release (104) . Cell culture experiments have shown that "replication factors" vary from cell type to cell type. Thus, by comparison with cells supporting full virus replication, certain cell types appeared to lack such factors at the receptor stage for poliomyelitis virus (65), at penetration for feline virus (155) , at uncoating for mouse hepatitis virus (136) , at viral nucleic acid synthesis and maturation for some PK-negative mutants of rabbit poxvirus (48) , and at maturation or envelopment for KB-negative mutants of adenovirus type 12, some DK mutants of herpes simplex virus, and Sendai virus (48) . Also, it is abundantly clear from experiments in culture that virus replication is influenced by changes in the environment of the cell. These include (65), and small molecular materials such as arginine (18) , leucine (50), yeast extract materials (27) , and some fatty acids (82) . Furthermore, replication in some cell types can be promoted by extracts of others (139) .
In animals, virus pathogenicity will be affected by variation of the availability of replication factors in particular hosts or (65) . The effect of temperature on virus virulence (14, 150) probably reflects temperature sensitivity of processes needed for virus production rather than an influence on host defense mechanisms, and the protective effect of fever on virus infection may result from a similar mechanism. Leucine enhanced vaccinia infection of mice as well as that of cell cultures (50), but similar animal experiments with arginine and appropriate viruses have not been done. Lack of the complete set of replication factors may result in production of defective virus particles which can influence virus infection by inducing host defenses against infective particles (69) . The spread of a virus in a host may be prevented-by a layer of insusceptible cells (i.e., those lacking replication factors), barring entry to a target organ; thus, a blood-borne virus unable to grow in vascular endothelium may not enter the brain, placenta, or skin tissues (98) .
In organ cultures, the defense mechanisms of the reticuloendothelial system and the inflammatory response are largely absent. Hence, the influence of replication factors on virus growth can be studied in a system removed to some extent from the influence of host defense factors without complete destruction of the in vivo character of experiments. Infection patterns in organ culture may parallel those in whole animals, for example, in the replication of rhinovirus in different human tissues (67) , infectious bovine rhinotracheitis virus in different bovine tissues (137), and influenza virus in different ferret tissues (16, 17) . In these cases, host defense mechanisms (other than those present or induced in infected cells) may not be as important in infection as replication factors. On the other hand, when the pattern of infection is not repeated in organ culture, for example, in growth of trachoma-inclusion conjunctivitis agents in baboon and guinea pig conjunctiva (115) , host defense mechanisms may be more important in pathogenicity in vivo. Comparisons of virulent and attenuated virus strains in organ cultures might reveal some aspects of the influence of replication factors on pathogenicity. Thus, in bovine pharyngeal epithelium, virulent strains of footand-mouth virus multiplied more rapidly and to a higher titer than attenuated strains (24) . Such investigations are rare. They should be extended to strains of other viruses and pressed deeper by using modifications of tissue culture methods, for example, one-step growth curves (56, 68) .
COUNTERACTING HOST DEFENSE MECHANISMS Although much has been written on host defense mechanisms against viruses (2, 15, 57, 65, 95, 98, 164) , little concrete information exists on the ability of viruses to counteract them (98, 105, 164) . In particular, there seem to be few studies of the early stages of virus infection (95) , where comparisons of the behavior of virulent and attenuated strains might reveal viral invasive mechanisms as they have done in bacteriology (143) . In this section, host defense mechanisms are summarized to form a background against which virus counteraction is described, and possible determinants of it are discussed. Nonspecific defense against virus infections is stronger in adult than young hosts (14, 20, 63, 102, 128) , is reduced by treatment with cortisone or X-rays (106, 150) , and contains both humoral and cellular factors. Humoral factors include the low pH of inflammatory exudates (65, 95, 164) and nonspecific virus inhibitors in tissues and serum. These inhibitors may be present before infection (103, 150) or be induced by it (156, 162) . Cellular factors include those present or induced in any tissue which the virus attacks, such as host nucleases capable of destroying virus nucleic acid (104) or interferon (15, 98) . There are probably also factors present in the phagocytic and other cells of the reticuloendothelial system (95) which can prevent the spread of viruses into susceptible tissues such as influenza virus into liver parenchyma (95) (60, 98, 113, 130, 167) .
In a preimmunized host, or a few days after primary infection, a virus must contend with the specific defenses of the host. Here, neutralizing antibodies supplement the nonspecific inhibitors in body fluids, and cellular viricidal mechanisms are strengthened by influence of these antibodies and immune lymphocytes (119) . Antibody may combine with surface components of the virus essential for host-cell penetration or opsonize the virus leading to phagocytosis and destruction by the macrophages (57, 95) . The virus-antibody combination can be reversed, and, although complement potentiates some combinations, it does not necessarily have a viricidal action (98) . In primary infection, immunoglobulin M may be more important than immunoglobulin G because of its earlier appearance. As regards cellular mechanisms, there is no clear evidence yet that macrophages from immune animals are more viricidal than normal macrophages (98) . But there are indications from the influence of antilymphocyte serum and from other experiments (72, 170) that immune lymphocytes are important in defense against some but not all virus infections; they may react with viral antigens and stimulate the infiltration and activity of macrophages. In some virus infections, such as those with cytomegalovirus and herpes simplex virus, there appears to be a dynamic equilibrium between virus replication and destruction by specific defenses, because immunosuppression can result in clinical disease (36, 101) .
Viruses break through host defenses to cause disease and, as for bacteria, this process depends not only on the strength of the defenses and the microbe's capacity to counteract them, but also on the number of invaders. A sufficiently large infecting dose can overwhelm the initial defenses of a susceptible host and cause irreparable damage before the induced defenses can be mounted. Thus, morbidity and mortality in Newcastle disease of chickens is directly related to dosage (164) , and Rift Valley fever virus will kill mice in only 6 hr if a high dose is given intravenously (98) . However, in natural disease and most laboratory experiments, a small infecting dose is involved. This must be built up to a population sufficiently large to cause damage against the activities of the host defense mechanisms that initially are heavily weighted against the few invading microbes. In the nonimmune host, defense mechanisms act at three overlapping stages. First there are those preexisting in the tissues. Then there are those induced fairly quickly and nonspecifically, such as interferon production and the inflammatory response. And finally there are the specific responses. Since many virus diseases are self-limiting (as regards pathological effects but not necessarily as regards virus elimination), it appears that even virulent strains of these viruses cannot withstand the specific responses which probably determine recovery from disease. Hence, in acute virus disease, the virulence mechanisms are first those which interfere with the two primary stages of host defense and then those which delay and possibly reduce the specific response to which viruses appear especially vulnerable.
Little is known about the resistance of viruses to the nonspecific viricidins in body fluids. Virulent strains of influenza virus appeared to resist these factors in serum more than avirulent strains (150), but possible reasons for the differential resistance, such as subtle differences in the envelope proteins of the strains, were not investigated. Similarly, alimentary tract viruses such as enteroviruses withstand a low pH, but the biochemical basis for this resistance is unknown.
Virus species and strains within species differ both in the amount of interferon they induce and in their susceptibility to it. Most of the work has been done in tissue culture. In many cases, virulent strains of viruses induce less interferon or are more resistant to it than attenuated strains, but there are instances when this is not so (14, 15, 25, 65, 89, 100, 120) . However, virus virulence is almost certainly determined by more than one mechanism. These mechanisms may be additive in their contributions to virulence rather than interdependent (cf., bacteria [140] ). Thus, a strict correlation between virulence and one factor such as induction of or resistance to interferon would not be expected. The role of interferon in virus infection is still not clearly estab-lished, owing to the difficulty of dissociating its action from more specific processes. Nevertheless, interferon is produced in vivo, and it is reasonable to assume that a capacity to reduce its production or resist its action would be an advantage to an invading virus. How could a virus achieve these ends? Strains which induce early inhibition of host cell ribonucleic acid (RNA) and protein synthesis would depress interferon production, and a blocker of interferon production-in vitro has been reported (31, 71) . Also, there are persistent reports of viruses producing in vitro antagonists of interferon-termed variously as stimulators, enhancers, and anti-interferons (29, 53, 61, 78, 135, 160) . The chemical nature of these substances is unknown, and whether they are produced in infection and play any role in virus invasion has yet to be assessed. Nevertheless, these interferon antagonists have been recognized, and some of them may prove to be viral counterparts to bacterial "aggressins" (143) . Similarly, if virus internal proteins can be proved to prevent the destruction of viral nucleic acids by host nucleases, as speculated by Newton (104), they might also qualify as viral "aggressins."
Some viruses are killed after ingestion by macrophages and others are not (57, 95, 98 (98) . Ingestion will probably be affected by the nature of the virus envelope, and serological and biochemical examination of the envelope proteins of strains differing in ease of ingestion might yield interesting results. Within the macrophage, the virus envelope may also play a role in virus survival by directly inhibiting viricidins, but it is equally possible that virus survival may be due to an overall inhibition of macrophage function by a cytotoxic action of the virus. Clearly some viruses such as myxoviruses, vaccinia virus, and measles virus exert cytotoxic effects on macrophages and inhibit phagocytic activity towards bacteria (57, 105, 130) . These cytotoxic effects may be a result of virus replication and thus come under the heading of damage to the host which could aid or hinder, according to the function of the macrophage, further invasion by the same virus or another pathogen. But they would have little relevance to the survival and replication of the initial infecting virus particles. On the other hand, the constituents of these initial particles might themselves inhibit macrophage function, including viricidal activity sufficient to allow their limited replication. Until we know more about the biochemical basis of virus cytotoxicity, we cannot decide between these possibilities and recognize the basis of virus survival and replication within macrophages. Similarly, we are ignorant of the reasons for the inhibition of phagocytic activity towards bacteria of polymorphonuclear leukocytes after treatment with viruses such as mumps virus, influenza virus, and coxsackievirus (105, 130) . If neutrophils contribute to defense against virus infection, such interference with their function by viruses may be a virulence mechanism.
Viruses could delay or reduce the protective effect of antibody by being present in such large amounts that any local antibody is swamped, by being "bad" antigens for inducing antibody, by antigenic variation, and by infecting and inhibiting the function of antibody-forming cells. Virus strains vary in their ability to evoke antibody (164) , and "slow vi-VOL. 36, 1972 297
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ruses," such as the scrapie agent, do not appear to induce antibody (169) . The reasons why some antigens are "good" and others "bad" are unknown (144) . The fact that viruses often have host-cell-membrane constituents in their envelope proteins provides the possibility of virus antigens being more "host-like" and therefore "bad" antigens, but this has not yet been proven. Furthermore, I am unaware of any comparison between virulent and attenuated strains of virus which has shown virulent strains to be the less immunogenic; it is usually the other way round (164) . Antigenic variation occurs in influenza virus, rhinoviruses, foot-and-mouth disease virus, and other viruses infecting the respiratory and alimentary tracts, and this must contribute to the ability of these viruses to attack fresh hosts which have neutralizing antibodies only against previous variants. But we do not have evidence that antigenic variation during the course of infection contributes to virulence as for example in protozoal diseases (147) . Some virus infections depress antibody synthesis, but it is not usually completely prevented. In some infections it is increased, for example, in Venezuelan encephalitis of mice and guinea pigs (105) . Like depression of macrophage activity, the way in which antibody-forming cells are inhibited is unknown. Also, in all experiments so far, the methods for detecting change in antibody production have not involved the infecting virus (98). Hence we do not know whether response to the latter was suppressed, the crucial point as regards counteraction of host defenses in primary virus infection.
Cellular immunity as judged by graft rejection or delayed hypersensitivity reactions is depressed in most virus infections (105) . Again, cellular immunity against the infecting virus has not been examined. Some viruses grow in lymphocytes and produce immunosuppression with or without cytotoxic damage (98) . The mechanisms of this intracellular growth are obscure but, like macrophage infection, lymphocyte infection provides a ready vehicle for spread of virus infection in some diseases such as those caused by ectromelia virus, distemper virus, tick-borne encephalitis virus, and lymphochoriomeningitis virus (98) .
HOST DAMAGE In attempts to understand the mechanisms responsible for the pathological effects of virus disease, four broad questions arise. Which pathological effects are specific to virus attack rather than nonspecific responses to general injury (153) ? Which cells are damaged by virus replication? Does this damage explain the specific pathological effects? And how is the damage produced?
In some cases, specific pathological effects are easy to detect, for example, paralysis in poliomyelitis resulting from damaged anterior horn tissue. On the other hand, the biochemical and pathological manifestations of shock that occur in poxvirus infections (149) are probably nonspecific responses to injury comparable to those found in anthrax (141) and malaria (51) . When such blanketing nonspecific responses occur, identifying the trigger mechanisms in virus diseases will prove more difficult than for bacterial diseases (45) . Unlike some bacterial toxins, the virus products responsible for the triggering effects have not been isolated (see below). Hence, infected animals or tissues must be used in all investigations. It is therefore difficult to distinguish the effects of virus replication (e.g., cellular amino acid changes due to virus-coded protein synthesis) from the results of damage to host tissue (e.g., cellular amino acid changes accompanying lysis), and there are also technical hardships in dealing with heavily infected animals. In bacteriology, the pathological syndrome has been studied successfully without interference from bacterial growth by removing bacteria with antibiotic treatment at a stage of the disease when the host was about to succumb (41) . This method might be adapted for virus work if replication but not the disease syndrome in animals or organ cultures could be stopped by methods comparable to those used in tissue culture (6 A direct connection between cell damage and specific pathological effects is perhaps strongest for those viruses which damage cells of the nervous system, for example, poliovirus and the encephalitis-producing viruses. Respiratory tract viruses such as rhinoviruses and influenza virus damage the epithelial cells of the respiratory tract with resultant local symptoms, and the destruction of some respiratory tract cells by influenza virus will ease the way for its well-known secondary invaders, pneumococci and staphylococci. But it is difficult to believe that the unpleasant systemic and sometimes fatal effects of influenza are merely due to damage of respiratory epithelium. Either the virus grows in and damages other sites or virus components (or host cell breakdown products) are liberated from the damaged respiratory epithelium, and, like bacterial toxins, have a toxic action elsewhere. In this connection, it is interesting that large doses of influenza virus are toxic (95, 149, 154) . Similarly, the systemic effects of viruses which produce rashes and skin pocks are possibly not directly connected with the skin cell damage but with damage elsewhere. If damage of host cells is widespread, then, as in malaria (112) , death may follow from the nonspecific pathological effects of pharmacologically active materials liberated from the damaged host cells. This may be the explanation for the fatal shock syndrome seen in some poxvirus infections (149) .
As suggested by Ginsberg (54) , virus-induced cell damage may result from a passive role of the virus-a simple repercussion of the process of replication, such as the depletion of cellular components essential for cell life or mechanical harm due to excessive production of virus or its components. Nevertheless, there is increasing evidence that two more positive processes of cell damage occur, namely, virus cytotoxic activity (6, 54) and immunological reaction of the host against virus-infected cells (119, 129, 165 (6) . Cells were also damaged by poliovirus, vaccinia virus, and rabbit poxvirus in the presence of chemical inhibitors of virus replication, such as p-fluorophenylalanine, and also by ultraviolet light-inactivated vaccinia virus, rabbit poxvirus, and reovirus (6) . In these experiments, high multiplicities of virus infection were used. Further support for the fact that virus replication and morphological damage need not be closely linked is provided by the observations that virulent strains of some viruses such as Newcastle disease virus (124, 125) have greater damaging effects in relation to replication rate than avirulent strains; and the damaging effects of the same virus, such as reovirus, in the same cell line can vary with different cultural conditions which provide similar yields of virus (45) . With regard to biochemical damage, the cut-off phenomenon (90) or inhibition of host-cell macromolecular synthesis can occur in the absence of the production of infectious virus. Thus, RNA and protein synthesis were depressed in poliovirus-infected HeLa cells treated with guanidine, which prevented replication (64) , and in cells treated with vesicular stomatitis virus after inactivation with ultraviolet light (163 castle disease virus, measles virus, and simian virus 5 produced rapid polykaryocytosis in cell cultures, but only when high virus multiplicities were used. This indicated that preformed products were responsible for the fusion effects and, in the experiments with simian virus 5, puromycin and actinomycin D were added to stop de novo protein synthesis (26, 66, 83, 107) . Components of herpesvirus also seem to produce syncytia (158) . The penton of adenovirus causes cell rounding and cell detachment from glass (46, 55) . A double-stranded RNA from bovine enterovirus caused rapid death, without the production of infectious virus, of cells susceptible and insusceptible to enterovirus infections (33) . Whether the RNA itself was cytotoxic or incomplete replication occurred giving rise to cytotoxic proteins is a matter of speculation (6) . Biochemical damage, more specifically interference with host-cell macromolecular synthesis, has been achieved with the fiber antigen of the adenovirus capsid which inhibited with RNA, deoxyribonucleic acid (DNA), and protein synthesis (88) and may have been achieved with a double-stranded RNA from poliovirus which interfered with protein synthesis in lysates of rabbit reticulocytes (44) . Finally, it is interesting to mention here that large quantities of some viruses, such as influenza virus and poxviruses, cause rapid toxic effects in animals (97, 149, 154 (85) , and Newcastle disease virus (124) . Also, in some instances, inhibition of host-cell macromolecular synthesis appears to be due to virus-induced protein synthesis (6, 90) .
Although virus-induced inhibition of hostcell macromolecular synthesis could produce decisive biochemical effects in animals (see above) and in time will kill cells, in several instances in tissue culture it appears that the rapid morphological damage of cells is not dependent on the "cut-off" phenomenon. comparable to that seen in vaccinia infection, did not suffer the rapid morphological damage seen in virus infection (6, 9) . Second, sequential observations of virus-infected cells sometimes coupled with treatment with compounds inhibiting RNA and protein synthesis showed a lack of parallelism between the appearance of morphological damage and the occurrence of the "cut-off" phenomenon for poliovirus (6), mengovirus (3, 59) , reovirus (45), influenza virus (133), simian virus (66), and herpesvirus (47) . Third, in the case of adenovirus, different parts of the capsid have different activities, the penton affecting morphology and the fiber antigen macromolecular synthesis (47, 88) . In investigating the nature and mode of action of the virus-induced compounds that are responsible for cytotoxic effects, preformed virion components (see above) are the easier target. By fractionating split virions, it should be possible to identify cytotoxic components such as the penton and fiber antigens of adenovirus and possibly the double-stranded RNA from bovine enterovirus. But the majority of cytotoxic compounds are probably extravirion compounds found in infected cells. Hence the task of identification is more difficult. Stephen and Birkbeck (151) advocated a direct approach comparable to that used in bacteriology, namely, to isolate the virus-induced components from infected cells, to free them from intact virus, and to attemptto produce the toxic effects in uninfected cells. This approach required the design of techniques for the difficult process of introducing potentially cytotoxic viral products into fresh cells. Using magnesium sulfate solutions to increase membrane permeability, Stephen and his colleagues (19) have obtained evidence of cytotoxic factors induced by vaccinia virus in HeLa cells. Furthermore, by using appropriate immunosorbents, they (168) have provided evidence that the infected cells contain both virus-specific and host-specific cytotoxic factors. Thus, there is increasing evidence that viruses produce cytotoxins; but how do they act? Inhibition of host-cell macromolecular synthesis or other interference with the functions of the cell could be produced directly by the virus product, as diphtheria toxin interferes with protein 300 SMITH on November 2, 2017 by guest http://mmbr.asm.org/ Downloaded from synthesis. On the other hand, the virus-induced product might release autolytic enzymes from the cell's own lysosomes (58) , and the results of Stephen and his colleagues are interesting in this respect. Obviously we are beginning to know something of the mechanisms of virus cytotoxicity, but much remains to be done in tissue culture and even more in relating the results of such experiments to pathological effects in animals.
Immunopathology is responsible for host damage in bacterial and other microbial diseases (143, 147) , but it is more likely to occur in virus diseases, because the obligate parasitism involved increases the chances of cellbound antigens occurring and also the existence of autoimmune phenomena. It is now clearly established that some viruses incorporate host-cell constituents, especially membrane constituents, into their structure. Hence antibodies against these virus-host complexes could react-with the membrane constituents of infected and normal cells. Also, virus infection may change the host-cell membrane constituents and form neoantigens, the antibodies against which could react with infected and normal cells.
Host damage could result from any of the four types of allergic reactions described by Coombs and Gell (32): type I, reaginic antibody-mediated anaphylactic reaction; type II, antibody and often complement-mediated cytotoxic reaction against cell-bound antigens; type III, antibody-antigen complex Arthustype reaction; and type IV, reaction of actively allergized cells without antibody. In addition to cell destruction, cell proliferation might also occur as a result of type II reactions (165) . It appears that one or more of these four types of allergic reactions may be involved, in some cases of damage, in a number of virus diseases such as encephalitis in measles, poxvirus rashes, pneumonia from respiratory syncytial virus, yellow fever, hemorrhagic dengue, mumps, coxsackie B virus infections, canine infective hepatitis, Kyasamur Forest disease, blue tongue of sheep, hog cholera, and Aleutian disease of mink (96, 165) . In these diseases, the evidence for immunopathology is mostly suggestive. But for lymphochoriomeningitis in mice, we have the viral counterpart of tuberculosis and streptococcal nephritis where sufficient solid experimental evidence has accumulated for us to be reasonably sure that immunopathology (glomerulonephritis from immune complex, type III reaction in chronic disease, and cytotoxic type II reaction involving antibody and complement in acute disease) plays a major role in the observed damage. This evidence has been so well described and reviewed that it need not be repeated here (40, 99, (108) (109) (110) (111) 165) .
Immunopathology is such an attractive explanation for virus damage that it is receiving much current attention (111, 129, 165) . Perhaps a few words of warning against too easy assumptions of its complicity in cases of virus damage may not be out of place. Firstly, mere demonstration that an infected host is immunologically sensitive to virus products by a diagnostic test such as a skin test is no proof of the implication of the sensitivity in the main pathological effects of disease. More extensive investigations are needed; the main systemic and local effects of the disease must be simulated by immunological reactions invoked in a sensitized host by products of the appropriate virus or in an infected host by antibody or immune cells from an immunized host. Such evidence is not easily obtained, particularly for human diseases lacking good animal models. Secondly, the lack of knowledge of the mechanisms of direct virus cytotoxicity adds to the difficulty of distinguishing such mechanisms from immunopathological ones. Thirdly, it should be remembered that, although interesting, the number of immunopathological cases is probably small compared with those due to direct virus cytotoxicity (165) .
HOST AND TISSUE SPECIFICITY The occurrence of host and tissue specificity in virus infections is so well documented (12, 65, 79, 149, 154 ) that descriptions of the many examples will not be repeated here. On the other hand, studies of the biochemical bases of these phenomena in virus infections are even more in their infancy than similar studies in bacteriology (12, 79, 115, 149) . The two phenomena are considered together, because broadly they can be explained on similar principles, although most of the examples deal with tissue specificity. It should be emphasized that the two specificities are not all-ornone phenomena (limited virus replication may well occur in the nonsusceptible tissue or host, especially if the infecting dose is high), and they often vary with the age of the host. Thus, coxsackievirus infects muscle cells of young but not old mice (76) , and the MHV (PRI) strain of mouse hepatitis virus infects liver macrophages of young but not old C 3H mice (12) .
The real difficulty in studies of host and VOL. 36, 1972 tissue specificity is not lack of ideas of possible explanations for the phenomena but the design of experimental systems to investigate them in a manner relevant to natural infection. Clearly, the availability of "replication factors" in host cells and their surrounding fluids and their variation under different environmental conditions probably determine many cases of host and tissue specificities (146, 147) . Similarly, other cases will depend on variation in levels of antiviral substances from host to host and tissue to tissue, or differential inductions of interferon and immune mechanisms either in level or in time (31, 65, 87) . Also, the route of infection may play some role in tissue specificity. One susceptible tissue may be easily accessible to the incoming virus and become infected, whereas another equally susceptible tissue may be protected by a barrier of cells which either do not support virus replication or destroy virus. For example, in mice the KUpffer cells of the liver seem to protect the parenchyma cells from infection with blood-borne influenza and myxoma viruses, and infection via the bile duct circumvents the barrier (95) . A blood-brain barrier appears to prevent infection of the brain by certain bloodborne viruses which attack neurons if inoculated directly into the central nervous system (14) . This barrier may be insusceptible vascular endothelial cells, but general reduction of the viremia by the cells of the whole reticuloendothelial system may be a major factor in the "blood-brain barrier" (75) . However, the latter does not seem to operate in some cases. Thus, in mice, an avirulent strain of Semliki Forest virus produced a viremia at least as high and probably higher than a virulent strain, yet its attack on the brain cells was abortive compared with the virulent strain whose lethal effect depended on rapid invasion and replication in the brain (121) . Despite the clear implication of route of infection in some cases of tissue specificity, variations of "replication factors" and host defense mechanisms are almost certainly more important in both tissue and host specificity, and methods of investigating them outside the animal host are discussed below.
The first essential is that the specificities of animal infection should be retained in the experimental system. Since virus susceptibilities change when cells differentiate in normal tissue cultures (12, 68, 77, 142) , the latter cannot be used directly to investigate host and tissue specificity in natural infection. Nevertheless, studies of differing cell susceptibilities in such cultures (48, 104) , might serve as models for adaptation to the systems described below.
Infection in the chick embryo has been recommended as a system in which tissue specificities characteristic of human and fowl infections can be reproduced for a number of viruses such as fowl pox, vaccinia, herpes, pseudorabies, influenza, Rous sarcoma, and Newcastle disease viruses (12, 22, 23) . However, this system does not appear to have been used extensively to investigate mechanisms of specificity, although experiments with whole embryos, primary chick cell cultures, and organ cultures could be conducted along the same lines as those described below. Thus, the difference in susceptibility between chicken lung cells and fibroblasts to Sendai virus appeared to be due to more efficient maturation of virus particles in the lung cells (38) .
Short-term studies with primary cell cultures or suspensions of relevant tissues have yielded most of our available information on tissue and host specificity. Using such preparations and membrane fractions from them, Bang (12) and Holland (65) provided good evidence that the presence or absence of surface receptors for poliovirus determined susceptibility or resistance to infection of different primate tissues and of primate and nonprimate tissues; in particular, cell resistance to infection disappeared when the receptors were by-passed by using virion RNA as the infecting material. In other cases, experiments with primary cell cultures have shown that the cell receptors determining initial adsorption are probably not the important factors in susceptibility. The MHV (PRI) strain of mouse hepatitis virus infects PRI mice but not C3H mice, and this difference in host specificity is reflected in the susceptibility of liver macrophages (12) . Yet adsorption of MHV (PRI) virus to resistant mouse (C 3H) macrophages was similar to that occurring with susceptible mouse (PRI) macrophages; penetration of the resistant macrophages seems to have occurred, but there appeared to be no uncoating (136) . Similarly, work with primary cell cultures showed initial adsorption, but absence of penetration occurred with insusceptible cells for Rous sarcoma virus (117) and feline herpesvirus (155) . Also, experiments with primary cell cultures of human fetal tissue, placenta, and leukocytes with Sendai and rubella viruses showed that interferon production varied with cell type and virus (10) .
In Influenza virus infection in the ferret seemed an appropriate system for study, since in ferrets influenza appeared to take the same course as in man, with a definite localization in the upper respiratory tract (49) . First, a quantitative survey of ferret organs for virus following inoculation intranasally or into the bloodstream was conducted to identify not only highly susceptible tissues but, for comparison, insusceptible ones and possibly those of intermediate susceptibility. One to five days after intranasal inoculation, of 16 different tissues examined, only nasal mucosa, lungs, trachea, and esophagus contained detectable virus. The nasal mucosa appeared the most susceptible tissue: the average total amounts of infective virus in lungs, trachea, and esophagus were approximately 2%, 0.001%, and 0.1%, respectively, of that in nasal mucosa. When virus was inoculated into the bloodstream, only nasal mucosa became infected and to a considerable degree. The high susceptibility of nasal mucosa to influenza virus was thus established; other workers reached similar conclusions (116) .
In organ cultures of ferret tissues, influenza virus infection followed the pattern in vivo for nasal mucosa, lung, trachea, esophagus, and aorta. After receiving the same inoculum, virus replicated significantly in nasal mucosa, lung, and trachea, and particularly well in nasal mucosa, but significant replication was not detected in the esophagus and aorta. Unexpectedly, organ cultures of bladder and oviduct (including the upper end of the uterus), which were not infected in the original experiments in vivo after intranasal or intracardial inoculation, supported virus growth. However, direct inoculation of ferrets into the bladder and upper end of the uterus resulted in local infection. The conclusions from the work thus far are as follows. First, influenza virus was more ubiquitous in infecting tissues than was first thought; the urogenital tract infection recalled reports of isolation of virus from urine VOL. 36, 1972 in some cases of human influenza (39) . Second, route of infection plays a most important part in localization of influenza virus in ferrets and probably man, since the incoming virus meets a highly susceptible tissue first, and other susceptible tissues are protected by a blood-tissue barrier which may be a reduction of viremia by the whole reticuloendothelial system, as suggested for the blood-brain barrier by Johnson and Mims (75) , or possibly an adsorption and inactivation by blood cells (S. Rosztoczy, G. L. Toms, and H. Smith, unpublished data). Third, some parallel had been established between infection in vivo and virus growth patterns in organ cultures, suggesting that "replication factors" rather than host defense mechanisms of the inflammatory and immune response play some role in tissue specificity. Fourth, highly susceptible, moderately susceptible, and poorly susceptible tissues had been indicated for future detailed comparison of their behavior when infected with influenza virus. Finally, factors which could vary in vivo and might be responsible for specificity differences, such as variations in temperature, pH, small molecular materials in the environment, and microbial flora, would not appear to play a decisive role in this example of tissue specificity. All these factors are standardized or controlled in the antibiotic-containing organ culture, the infection pattern of which paralleled the susceptibilities in vivo.
Deeper investigations on the differing susceptibilities of the organ cultures could be based on the methods and approaches which have had some success in studies of the susceptibility of tissue culture cells (48, 104) and primary cell cultures (see above). Single-cycle growth experiments with varying virus inocula and coupled with treatment with antiserum at different stages could be attempted to investigate more closely the stages of virus replication in poorly, moderately, and highly susceptible tissues. Investigations of receptors could be conducted by the methods used by Holland (65) for poliovirus, including infection experiments with viral nucleic acid and destruction of receptors by the Vibrio cholerae enzyme (neuraminidase). Attempts could be made to transfer susceptibility or resistance by isolated membranes or extracts from the various organ cultures or by feeder techniques using susceptible and poorly susceptible tissues in close proximity to one another. It is also possible that different strains of virus with a different envelope protein or neuraminidase may be blocked in infecting the normally highly susceptible nasal mucosa and thus provide some clue as to the important step in susceptibility. All these types of experiments are possible, but for their operation and interpretation the organ culture system has two serious disadvantages. First, in organ culture, cell types differ and only a relatively small proportion of them may be susceptible to infection; in fact, differences in susceptibility of organ cultures (and the parent tissue in vivo) may be merely a reflection of the relative number of susceptible cells rather than differences in inherent susceptibility of the cells. Second, organ cultures have cut edges and under-surfaces which will expose previously unexposed cells to virus attack, at least at the start of infection in vivo; virus attachment to or replication in these cells may confuse an issue. Some method, such as immunofluorescence or electron microscopy, of checking where virus attachment and replication is occurring in the different cell types of organ culture would seem an essential adjunct to the experimental approaches described above. Overall, it seems to me and my colleagues (S. Rosztoczy, G. L. Toms, and H. Smith, unpublished data) that only if susceptibility or resistance is determined by differential numbers of susceptible cells in the tissue or at early stages in replication (such as absorption, penetration, and possibly uncoating) is the organ culture system capable of providing the answers at its present stage of sophistication.
In a first attempt at such deeper investigations (56), infection of ferret nasal mucosa and esophagus were compared in experiments based on single-cycle growth studies. Virus adsorbed with equal efficiency to both tissues. Electron microscopy showed virus directly adsorbed to the cilia and cell surfaces of the respiratory tissue. However, in contrast to the nasal mucosa, virus adsorbed to esophagus appeared to be mainly associated with an amorphous substance covering the epithelial cells and rarely in direct contact with the cell membrane. Subsequently, virus penetrated the cells of the nasal mucosa, and large amounts of newly synthesized virus were recovered withinreason for the relative insusceptibility of esophagus to influenza infection. On the other hand, the reason for the high susceptibility of nasal mucosa is not clear. A strong adherence to the cilia and microvilli was observed in this and other work (41) . Obviously the presence of cilia and microvilli is not essential for adsorption and penetration, since nonciliated cells of ferret bladder were susceptible to infection both in vivo and in vitro.
In conclusion, this review will have achieved its purpose if it encourages some virologists well versed in the elegant methods of tissue culture to turn their attention and adapt their methods to less well-defined organ culture and whole animal systems. In this way we may learn more about virus disease, the raison d'6tre for our subject.
